ARQT – arcutis biotherapeutics, inc. - common stock (US:NASDAQ)

News

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arcutis Biotherapeutics: Betting Big On Zoryve [Seeking Alpha]
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 [Yahoo! Finance]
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Pigmentation Disorder Treatment Market Aims for Remarkable Growth, Targeting USD 11.40 Billion by 2032 at 5% CAGR [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com